Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:754 (7 October), doi:10.1136/bmj.333.7571.754-a
| The first 150 words of the full text of this article appear below. |
EDITORWhile naloxone is a good drug for resuscitation we should beware its other characteristics.1 Naloxone has a short half life and so may give unskilled users a false sense of security, introducing a "secondary opiate overdose," particularly when used to treat overdose with a long acting opiate such as methadone. The authors cite 440 "reversals" (an unfortunate misnomer for a competitive antagonist) of 6000 doses distributed: what happened to the other 5560 doses? There is a risk that these were used to avoid calling emergency services as drug users associate emergency ambulance services with police. Or unsuccessful use may have been unreported and some patients died despite attempted inhibition. How many died after "reversal" or required further "reversal"? Furthermore, opiate blocking drugs can provide a useful punishment tool for drug dealers who may use the drug as a method of ensuring compliance with their demands.
In the same
Andrew J Ashworth, general practitioner
Davidson's Mains Medical Centre, Edinburgh EH4 5BP Andrew.Ashworth@lothian.scot.nhs.uk
Read all Rapid Responses